Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is a recent innovation in minimally invasive surgery which has already proven its non-inferiority to conventional abdominal laparoscopy (CAL) for hysterectomy in terms of efficiency and safety. However, the investigators note a lack of medical literature and no specific randomized controlled trial (RCT) assessing women's sexual function after vNOTES for benign adnexal surgery. The aim of this RCT is to confirm the non-inferiority of the vNOTES approach for benign adnexal pathology compared to CAL on women's sexual function. Secondary outcomes will evaluate vNOTES's efficiency, morbidity and postoperative complications compared to CAL for benign adnexal surgery. The relationship between adnexal mass morcellation/aspiration and the quality of the histological analysis on surgical specimens will also be evaluated as secondary outcome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Women's quality of sexual life evaluation - Female Sexual Function Index (FSFI)
Timeframe: Preoperative
Women's quality of sexual life evaluation - Female Sexual Function Index (FSFI)
Timeframe: 3 months postoperative
Women's quality of sexual life evaluation - Female Sexual Function Index (FSFI)
Timeframe: 6 months postoperative
Women's quality of sexual life evaluation - Couple Satisfaction Index-16 (CSI-16)
Timeframe: Preoperative
Women's quality of sexual life evaluation - Couple Satisfaction Index-16 (CSI-16)
Timeframe: 3 months postoperative
Women's quality of sexual life evaluation - Couple Satisfaction Index-16 (CSI-16)
Timeframe: 6 months postoperative
Women's quality of sexual life evaluation - Self reported questionnaire on dyspareunia
Timeframe: Preoperative
Women's quality of sexual life evaluation - Self reported questionnaire on dyspareunia
Timeframe: 3 months postoperative
Women's quality of sexual life evaluation - Self reported questionnaire on dyspareunia
Timeframe: 6 months postoperative